343 related articles for article (PubMed ID: 3549705)
21. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
[TBL] [Abstract][Full Text] [Related]
22. Predictive value of symptoms of atypical depression for differential drug treatment outcome.
McGrath PJ; Stewart JW; Harrison WM; Ocepek-Welikson K; Rabkin JG; Nunes EN; Wager SG; Tricamo E; Quitkin FM; Klein DF
J Clin Psychopharmacol; 1992 Jun; 12(3):197-202. PubMed ID: 1629387
[TBL] [Abstract][Full Text] [Related]
23. Maprotiline versus imipramine and placebo in neurotic depression.
van der Velde CD
J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
[TBL] [Abstract][Full Text] [Related]
24. Nomifensine vs. imipramine in depressed inpatients.
Fann WE; Lyle FA; Higginbotham W
J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):60-2. PubMed ID: 6370978
[TBL] [Abstract][Full Text] [Related]
25. Phenelzine v imipramine in atypical depression. A preliminary report.
Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin J; Tricamo E; Markowitz JS; Klein DF
Arch Gen Psychiatry; 1984 Jul; 41(7):669-77. PubMed ID: 6375621
[TBL] [Abstract][Full Text] [Related]
26. Implications of restrictive diagnosis for compliance to antidepressant drug therapy: alprazolam versus imipramine.
Overall JE; Donachie ND; Faillace LA
J Clin Psychiatry; 1987 Feb; 48(2):51-4. PubMed ID: 3542984
[TBL] [Abstract][Full Text] [Related]
27. Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical study.
McEvoy JP; Libiger J; Wilson WH; Ban TA; Berney S; Guy W
J Clin Psychiatry; 1982 Mar; 43(3):111-2. PubMed ID: 7037758
[TBL] [Abstract][Full Text] [Related]
28. Antidepressant specificity in atypical depression.
Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison WM; Markowitz JS; Rabkin JG; Tricamo E; Goetz DM; Klein DF
Arch Gen Psychiatry; 1988 Feb; 45(2):129-37. PubMed ID: 3276282
[TBL] [Abstract][Full Text] [Related]
29. A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression.
McGrath PJ; Stewart JW; Nunes EV; Ocepek-Welikson K; Rabkin JG; Quitkin FM; Klein DF
Am J Psychiatry; 1993 Jan; 150(1):118-23. PubMed ID: 8417553
[TBL] [Abstract][Full Text] [Related]
30. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
Cohn CK; Robinson DS; Roberts DL; Schwiderski UE; O'Brien K; Ieni JR
J Clin Psychiatry; 1996; 57 Suppl 2():15-8. PubMed ID: 8626358
[TBL] [Abstract][Full Text] [Related]
31. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
Quitkin FM; Stewart JW; McGrath PJ; Tricamo E; Rabkin JG; Ocepek-Welikson K; Nunes E; Harrison W; Klein DF
Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065
[TBL] [Abstract][Full Text] [Related]
32. Phenelzine treatment of melancholia.
McGrath PJ; Stewart JW; Harrison W; Wager S; Quitkin FM
J Clin Psychiatry; 1986 Aug; 47(8):420-2. PubMed ID: 3525522
[TBL] [Abstract][Full Text] [Related]
33. Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders.
Baca E; Garcia-Garcia M; Porras-Chavarino A
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):57-65. PubMed ID: 14687858
[TBL] [Abstract][Full Text] [Related]
34. Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study.
Robinson DS; Lerfald SC; Bennett B; Laux D; Devereaux E; Kayser A; Corcella J; Albright D
Psychopharmacol Bull; 1991; 27(1):31-9. PubMed ID: 1862204
[TBL] [Abstract][Full Text] [Related]
35. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine.
Kosten TR; Frank JB; Dan E; McDougle CJ; Giller EL
J Nerv Ment Dis; 1991 Jun; 179(6):366-70. PubMed ID: 2051152
[TBL] [Abstract][Full Text] [Related]
36. A double-blind comparison of gepirone extended release, imipramine, and placebo in the treatment of outpatient major depression.
Feiger AD
Psychopharmacol Bull; 1996; 32(4):659-65. PubMed ID: 8993088
[TBL] [Abstract][Full Text] [Related]
37. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
Stark P; Hardison CD
J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
[TBL] [Abstract][Full Text] [Related]
38. Pretreatment dexamethasone suppression test as a predictor of response to phenelzine.
Janicak PG; Pandey GN; Sharma R; Boshes R; Bresnahan D; Davis JM
J Clin Psychiatry; 1987 Dec; 48(12):480-2. PubMed ID: 3693333
[TBL] [Abstract][Full Text] [Related]
39. Long-term therapy for depression with trazodone.
Fabre LF; Feighner JP
J Clin Psychiatry; 1983 Jan; 44(1):17-21. PubMed ID: 6337131
[TBL] [Abstract][Full Text] [Related]
40. A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.
Cohn JB; Wilcox C
J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):26-31. PubMed ID: 3882677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]